Edgewise Therapeutics, Inc. (EWTX)
EWTX price $39.65 -0.10 -0.25%
- Ticker
- EWTX
- Price
- $39.65
- Change
- -0.10 -0.25%
- Market cap
- $4.27B
- P/E
- -21.49
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 54
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1…